How can we better predict treatment outcomes in classical Hodgkin's lymphoma?
作者信息
Agostinelli Claudio
机构信息
Section of Haematopathology, Institute of Haematology & Clinical Oncology 'L&A Seragnoli', S.Orsola-Malpighi Hospital, via Massarenti 9, 40138, Bologna, Italy.
出版信息
Int J Hematol Oncol. 2017 Nov;6(3):65-68. doi: 10.2217/ijh-2017-0010. Epub 2017 Nov 20.
Abstract
摘要
相似文献
1
How can we better predict treatment outcomes in classical Hodgkin's lymphoma?
Int J Hematol Oncol. 2017 Nov;6(3):65-68. doi: 10.2217/ijh-2017-0010. Epub 2017 Nov 20.
2
The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study.
Lancet Haematol. 2016 Oct;3(10):e467-e479. doi: 10.1016/S2352-3026(16)30108-9.
3
Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group.
Lancet Oncol. 2017 Apr;18(4):454-463. doi: 10.1016/S1470-2045(17)30103-1. Epub 2017 Feb 22.
4
CD20 positivity in classical Hodgkin's lymphoma: Diagnostic challenge or targeting opportunity.
Indian J Pathol Microbiol. 2009 Jan-Mar;52(1):6-9. doi: 10.4103/0377-4929.44952.
5
Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
Mod Pathol. 2003 Jun;16(6):566-73. doi: 10.1097/01.MP.0000071843.09960.BF.
6
Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study.
Lancet Haematol. 2015 Feb;2(2):e55-65. doi: 10.1016/S2352-3026(14)00039-8. Epub 2015 Jan 20.
7
Microenvironment-related biomarkers and novel targets in classical Hodgkin's lymphoma.
Biomark Med. 2015;9(8):807-17. doi: 10.2217/BMM.15.30. Epub 2015 Jul 30.
8
Histopathology of Hodgkin's lymphoma.
Cancer J. 2009 Mar-Apr;15(2):129-37. doi: 10.1097/PPO.0b013e31819e31cf.
9
Chemotherapy and radiotherapy in Hodgkin's lymphoma: joining in or splitting up?
Curr Opin Oncol. 2006 Nov;18(6):660-6. doi: 10.1097/01.cco.0000245315.05263.fb.
10
Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma by array-based comparative genomic hybridization.
Haematologica. 2008 Sep;93(9):1318-26. doi: 10.3324/haematol.12875. Epub 2008 Jul 18.
本文引用的文献
1
Meta-analysis of the prognostic and clinical value of tumor-associated macrophages in adult classical Hodgkin lymphoma.
BMC Med. 2016 Oct 17;14(1):159. doi: 10.1186/s12916-016-0711-6.
2
The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study.
Lancet Haematol. 2016 Oct;3(10):e467-e479. doi: 10.1016/S2352-3026(16)30108-9.
3
The prognostic value of the myeloid-mediated immunosuppression marker Arginase-1 in classic Hodgkin lymphoma.
Oncotarget. 2016 Oct 11;7(41):67333-67346. doi: 10.18632/oncotarget.12024.
4
Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma.
N Engl J Med. 2016 Jun 23;374(25):2419-29. doi: 10.1056/NEJMoa1510093.
5
US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816.
J Clin Oncol. 2016 Jun 10;34(17):2020-7. doi: 10.1200/JCO.2015.63.1119. Epub 2016 Apr 11.
6
PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study.
Blood. 2016 Mar 24;127(12):1531-8. doi: 10.1182/blood-2015-11-679407. Epub 2016 Jan 8.
7
The prognostic value of positron emission tomography performed after two courses (INTERIM-PET) of standard therapy on treatment outcome in early stage Hodgkin lymphoma: A multicentric study by the fondazione italiana linfomi (FIL).
Am J Hematol. 2015 Jun;90(6):499-503. doi: 10.1002/ajh.23994. Epub 2015 May 10.
8
The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale.
Haematologica. 2014 Jun;99(6):1107-13. doi: 10.3324/haematol.2013.103218. Epub 2014 Mar 21.
9
Gene expression-based model using formalin-fixed paraffin-embedded biopsies predicts overall survival in advanced-stage classical Hodgkin lymphoma.
J Clin Oncol. 2013 Feb 20;31(6):692-700. doi: 10.1200/JCO.2012.43.4589. Epub 2012 Nov 26.
10
Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial.
Blood. 2012 Oct 18;120(16):3280-7. doi: 10.1182/blood-2012-04-421057. Epub 2012 Sep 4.
Zotero 插件